BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Pharm Country

  Senesco Technologies, Inc. Announces $1.725 Million Equity Financing

  October 1, 2013

   · 

  1 min read
• Business

  CryoXtract™ Instruments Enters Distribution Agreement for Australia and New Zealand With Bio-Strategy Ltd.

  October 1, 2013

   · 

  1 min read
• Lone Star Bio

  Mystic Pharmaceuticals Receives Notices of Allowance From Japan and China on Drug Delivery Platform Technologies

  October 1, 2013

   · 

  1 min read
• Business

  NeuroMetrix, Inc. Appoints David Van Avermaete to Board of Directors

  October 1, 2013

   · 

  1 min read
• Policy

  Cerus Corporation Submits the First of Three Modules in the Premarket Approval (PMA) Application Process for INTERCEPT Platelets

  October 1, 2013

   · 

  1 min read
• EffRx Receives Prestigious EUR 5.9 Million FP7 Research Grant for the Development of EX404 for Polycystic Ovary Syndrome (PCOS) in Paediatric Populations

  October 1, 2013

   · 

  1 min read
• Genetown

  PHT Clinical Science and Consulting Expands to Meet Growing eClinical Demand for Clinical Outcomes Assessment (COA) Expertise

  October 1, 2013

   · 

  1 min read
• Business

  MEDICREA Release : Results for the 1st Half of 2013

  October 1, 2013

   · 

  1 min read
• Deals

  Asterias Biotherapeutics, Inc., a Subsidiary of BioTime, Acquires Geron Corporation’s Embryonic Stem Cell Assets

  October 1, 2013

   · 

  1 min read
• Teva Pharmaceutical Industries Limited Announces Launch of Generic Zemplar® in the United States

  October 1, 2013

   · 

  1 min read